Is LifeStance Health Group, Inc. (LFST) Overvalued?
We dive into why LifeStance Health Group, Inc. (LFST) could be considered overvalued on 2026-07-30, based on AAII’s Value Score and Grade.Jenna Brashear
Stock Evaluator: LifeStance Health Group, Inc. (LFST)
LifeStance Health Group, Inc. LFST
$10.48
-0.26
-2.42%
July 31, 2026 4:00:00 PM
EST
Volume: 2,524,932
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Commentary & Analysis
Which Is a Better Investment, LifeStance Health Group, Inc. or NeoGenomics, Inc. Stock?
Learn more about whether LifeStance Health Group, Inc. or NeoGenomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Which Is a Better Investment, Clover Health Investments, Corp. or LifeStance Health Group, Inc. Stock?
Learn more about whether Clover Health Investments, Corp. or LifeStance Health Group, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Michael Rose
Why LifeStance Health Group, Inc.’s (LFST) Stock Is Down 11.64%
As of Friday, May 08, LifeStance Health Group, Inc.’s LFST share price has dipped by 11.64%, which has investors questioning if this is right time to buy.Jenna Brashear
Why LifeStance Health Group, Inc.’s (LFST) Stock Is Down 12.09%
As of Friday, May 08, LifeStance Health Group, Inc.’s LFST share price has dipped by 12.09%, which has investors questioning if this is right time to buy.Omar Beirat
Financial Summary
| Share Statistics | LFST | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4,064.5 | $1,742.7 | 64% |
|
| Shares Out (Mil) | 395.1 | 76.7 | 86% |
|
| Institutional Ownership | 93.8% | 89.7% | 64% |
|
| Float (Mil) | 238.7 | 49.4 | 77% |
|
| Beta | 1.19 | 0.82 | 70% |
|
| Avg Daily Volume (000s) | 2,214 | 521 | 84% |
|
| Price Change (52-week) |
147.8% | 78.7% | 96% |
|
| Growth | LFST | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 30.4% | 11.0% | 90% |
|
| Net Income (5yr) | 17.7% | (0.7%) | 69% |
|
| EPS (5yr) | 15.1% | 3.1% | 56 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 11.4% | (18.0%) | 70% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 5 | 5 | |
| Current EPS | $0.082 | $0.311 | $0.392 | |
| Month Ago EPS | $0.082 | $0.311 | $0.392 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.068 | $0.301 | $0.382 | |
| Year/Year Chg | 121.6% | 1,455% | 2,280% | |
| Financials | LFST | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,495 | $1,456 | 56% |
|
| Net Income (TTM) (Mil) | $23 | $12 | 50% |
|
| EPS (TTM) | $0.060 | $0.300 | 42% |
|
| Operating Cash Flow (TTM) (Mil) | $182 | $138 | 58% |
|
| Net Cash Flow (TTM) (Mil) | $61 | $8 | 73% |
|
| Long-Term Debt (Q1) (Mil) | $411 | $316 | 57% |
|
| Enterprise Value (Q1) (Mil) | $3,156 | $2,170 | 55% |
|
| Valuation | LFST | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.75 | 2.85 | 62% |
|
| P/E | 180.7 | 26.7 | 97% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 12.0 | 1.1 | 95% |
|
| Ratios | LFST | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 32.6% | 27.8% | 39% |
|
| Net Margin | 1.6% | 1.1% | 37% |
|
| ROA | 1.1% | 1.8% | 48% |
|
| ROE | 1.6% | 7.1% | 38% |
|
| Liabilities to Assets | 31.2% | 59.9% | 22% |
|
| F-Score | 8 | 5 | 94% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Kirkpatrick Growth Screen
Factors: Momentum, Growth
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 14.2% |
| +/- S&P 500: | +6.7 |
